Royalty Pharma (RPRX) Goodwill & Intangibles (2019 - 2026)

Royalty Pharma has disclosed Goodwill & Intangibles across 5 years of filings, most recently posting $923.5 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles changed 0.12% year-over-year to $923.5 million; the TTM figure through Jun 2026 stood at $923.5 million (changed 0.12% YoY), while the FY2025 annual figure was $924.6 million, changed N/A from the prior year.
• Goodwill & Intangibles came in at $923.5 million for Q2 2026 at Royalty Pharma, roughly flat from $924.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $924.6 million in Q2 2025 to a low of $923.5 million in Q2 2026.